Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Trial of Hematopoietic Stem Cells in Acute Myocardial Infarction [Phase 2]
A Phase 2 clinical trial is evaluating hematopoietic stem cell therapy in patients with reperfused acute myocardial infarction. The current …
-
FDA approval · 2010-01-28FDA Approved: QUINAPRIL — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for Quinapril submitted by Cipla USA Inc. The approval confirms continued availability of Quinapril …
-
FDA approval · 2010-01-28FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved a supplemental application for enalapril maleate from Taro Pharmaceuticals U.S.A., Inc., authorizing the generic product under …
-
CLINICAL_TRIALS withdrawal · 2010-01-28Clinical Trial Update: Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients [Phase 4]
A Phase 4 trial comparing intravenous and sublingual isosorbide dinitrate for relief of acute anginal episodes in acute coronary syndrome ha…
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome [Phase 4]
A Phase 4 trial comparing dalteparin with unfractionated heparin in acute coronary syndrome was terminated. Results from the study were post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2010-01-26EMA Withdrawn: Clopidogrel BMS (clopidogrel (as hydrogen sulfate)) — Bristol-Myers Squibb Pharma EEIG
The EMA information indicates that the clopidogrel BMS product (clopidogrel as hydrogen sulfate) has been withdrawn from the market.
-
CLINICAL_TRIALS trial_result · 2010-01-25Clinical Trial Update: Effects of Cardiac Rehabilitation on High Mobility Group Box-1 Levels After Acute Myocardial Infarction [NA]
This update presents results from a completed trial investigating whether cardiac rehabilitation affects high mobility group box-1 (HMGB1) l…
-
CLINICAL_TRIALS trial_result · 2010-01-22Clinical Trial Update: Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study [Phase 2]
A Phase 2 trial (MYSTAR) from the Medical University of Vienna evaluated administration of myocardial stem cells after acute myocardial infa…
-
FDA approval · 2010-01-19FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for metoprolol tartrate submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2010-01-05Clinical Trial Update: Randomized Trial of Immediate Versus Early and Selective Invasive Percutaneous Coronary Intervention in NSTEMI [Phase 4]
This Phase 4 randomized trial compared immediate versus early and selective invasive percutaneous coronary intervention in non-ST-elevation …
-
CLINICAL_TRIALS trial_result · 2009-12-18Clinical Trial Update: Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Patients Presenting With Chest Pain
This clinical trial update indicates the completion of the observational multimarker study Triage Now in patients presenting with chest pain…
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: Clinical Study to Examine the Effects of Erythropoietin on Left Ventricular Function After Acute Myocardial Infarction [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating the effects of erythropoietin on left ventricular function after…
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling [Phase 1]
The BELIEVE study, a Phase 1 trial evaluating nesiritide for post-myocardial infarction left ventricular modeling, sponsored by Mayo Clinic,…
-
CLINICAL_TRIALS trial_result · 2009-12-01Clinical Trial Update: Study of the Effectiveness of Report Cards on the Quality of Care for Heart Attack and Heart Failure Patients [NA]
This completed clinical trial evaluated whether providing performance report cards improves the quality of care for patients with acute myoc…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients [Phase 2]
Phase 2 clinical trial update reporting results related to prothrombin time excursions outside the therapeutic range in otherwise stable pat…
-
FDA approval · 2009-11-18FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for lisinopril from Quallent Pharmaceuticals Health LLC, approving this generic lisinopril product.
-
CLINICAL_TRIALS trial_result · 2009-11-10Clinical Trial Update: Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism [Phase 4]
A Phase 4 trial comparing adjunctive cilostazol versus high maintenance-dose clopidogrel in acute myocardial infarction patients, examining …
-
CLINICAL_TRIALS trial_result · 2009-11-03Clinical Trial Update: Autologous Bone Marrow Transplanted Via Transendocardial Catheter to Chronic Myocardial Infarct Border Zone [Phase 1]
Phase 1 study evaluating autologous bone marrow transplantation delivered via a transendocardial catheter in patients with ventricular dysfu…
-
CLINICAL_TRIALS withdrawal · 2009-11-03Clinical Trial Update: A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN) [Phase 2]
A Phase 2 safety and efficacy trial evaluating fondaparinux in percutaneous coronary intervention has been withdrawn.
-
CLINICAL_TRIALS research · 2009-11-02Clinical Trial Update: Antiplatelet Therapy Continuation in Spine Surgery - Its Effect on Postoperative Morbidity and Mortality
This document reports an update on a clinical trial evaluating whether continuing antiplatelet therapy after spine surgery affects postopera…
-
FDA approval · 2009-10-29FDA Approved: RAMIPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA granted supplemental approval for Lupin Pharmaceuticals’ ramipril generic under the ANDA, authorizing continued marketing of the product…
-
FDA approval · 2009-10-22FDA Approved: RAMIPRIL — Supplemental Application (Chartwell RX, LLC.)
FDA approved a supplemental application for RAMIPRIL submitted by Chartwell RX, LLC., indicating approval of a supplemental filing related t…
-
FDA approval · 2009-10-22FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for ramipril submitted by Hikma Pharmaceuticals USA Inc. The action confirms continued approval …
-
CLINICAL_TRIALS trial_result · 2009-10-06Clinical Trial Update: Rule Out Myocardial Infarction by Computer Assisted Tomography
A completed Massachusetts General Hospital study evaluated using computer-assisted tomography to rule out myocardial infarction in patients …
-
CLINICAL_TRIALS trial_result · 2009-10-05Clinical Trial Update: Coronary Care Caffeine: Influence of Coffee on Heart Rate Post Myocardial Infarction
A completed trial investigated whether caffeine from coffee influences heart rate in patients after myocardial infarction.